Breast Cancer in Young Women Conference - OECI

FACULTY
O. Abulkhair, King Abdulaziz Medical City for National Guard, Riyadh, SA
S. Aebi, Luzerner Kantonsspital, Lucerne, CH
F. Amant, U.Z Gasthuisberg, Leuven, BE
C. Anders, UNC Linenberger Comprehensive Cancer Center, Chapel Hill, US
J. Armstrong, St. Luke’s Institute of Cancer Research, Dublin, IE
A.G. Arnold, Memorial Sloan-Kettering Cancer Center, New York, US
H.A. Azim Jr., Jules Bordet Institute, Brussels, BE
F.A. Calvo, Hospital General Universitario Gregorio Marañon, Madrid, ES
F. Cardoso, Champalimaud Cancer Center, Lisbon, PT
A.M. Cluxton, Young Survival Coalition, Columbus, US
R.E. Coleman, Weston Park Hospital, Sheffield, UK
M. Colleoni, European Institute of Oncology, Milan, IT
E. Connolly, St. James Hospital, Dublin, IE
A. Costa, European School of Oncology, Milan, IT
J. Crown, NICB Dublin City University, Dublin, IE
S. Delaloge, Institut Gustave Roussy, Villejuif, FR
J. Dix, Adoption Consultant, Isle of Wight, UK
G. Freilich, Europa Donna, London, UK
E. Furlong, University College Dublin, Dublin, IE
T. Gagliardi, Aberdeen Royal Infirmary, Foresterhill Aberdeen, UK
J. Garber, Dana Farber Cancer Institute, Boston, US
O.D. Gentilini, European Institute of Oncology, Milan, IT
J. Geraghty, St Vincent’s Hospital, Dublin, IE
A. Graziottin, Saint Raffaele Resnati Hospital, Milan, IT
A. Green, School of Medicine & Medical Science, Dublin, IE
N. Harbeck, Breast Center, University of Munich, DE
B. Kaufman, Sheba Medical Center, Tel Hashomer, IL
M. Kell, University College Dublin, Dublin, IE
C. Kelly, Mater Misericordiae Hospital, Dublin, IE
J. King, Royal Free Hampstead NHS Trust, London, UK
M.C. King, University of Washington - School of Medicine, Seattle, US
C.K. Kuhl, Aachen University Clinic, Aachen, DE
S. Loibl, German Breast Group, Neu-Isenburg, DE
E.W. McDermott, St. Vincent Hospital, Dublin, IE
D. Meirow, Sheba Medical Center, Tel Aviv, IL
E. Mocanu, Rotunda Maternity Hospital, Dublin, IE
A. O’Doherty, National Cancer Screening Service, Dublin, IE
G. O’Dowd, Irish Cancer Society, Dublin, IE
O. Pagani, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
S. Paluch-Shimon, Sheba Medical Center, Tel Hashomer, IL
A.H. Partridge, Dana-Farber Cancer Institute, Boston, US
F.A. Peccatori, European Institute of Oncology, Milan, IT
I. Smith, Royal Marsden Hospital, Sutton Surrey-London, UK
A. Tutt, Kings College London School of Medicine, Guy’s Hospital Camp, London, UK
:: 4 ::